8Fibich C, Rohrberg R,Sommer H, et al. Long-term-follow-up of a phase Ⅰ-Ⅱ study of myco-phenolate-mofetil (MMf) in refractory Evans syndrome[J]. Blood,2001,98(2) :442a.
4Vadhan-Raj S,Murray L J,Bueso-Ramos C et al.Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patinents with cancer.Ann Intern Med,1997,126: 678
5Hoshi S,Yoshitomi H,Komatsu N et al.Megakaryocytopoietic activity of a truncated variant of mouse thrombopietin.J Biophys Commun,1997,231: 823
6O'Malley C J,Rasco J E,Basser R L et al.Administration of PEG-rHuMGDF to human stimulates the production of functional platelets that show no evidence of in vivo activiation.Blood ,1996,88: 3288
7Harker L A,Roskos J E,Marzec U M et al.Effects of megakaryocyte growth and development factor on platelet production,platelet life span,and platelet function in healthy human volunteers.Blood,2000,95: 2514
8[1]Bartley TD, Bogenberger J, Hunt P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl [J]. Cell, 1994;77(7):1117-1124.
9[2]Lok S, Kaushansky K, Holly RD, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo[J]. Nature, 1994; 369(6481):565-568.
10[3]Vadhan-Raj S. Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia[J]. Semin Hematol, 2000; 37(2 Suppl 4):28-34.
